Extensive article in today's Wall Street Journal entitled "An Outcast Among Peers Gains Traction on Alzheimer's Cure" No mention of Prana's work or of their metals theory .......
Outcasts by choice. Didn't submit any claims for peer review in 2008. Smells a bit. Lets see. The amyloid build up comes before the Tau misfolding. PBT2 works against both.
Sentiment: Strong Buy
Kad: So, if he's so sketchy, wonder how he got page 1 coverage in the WSJ? Are their AZ reporters that naive?
Link to WSJ article: http://online.wsj.com/article/SB10000872396390443624204578060941988428604.html
No wonder because he is (Professor of Gerotology and Old Age Psychiatry at Aberdeen University) an Executive chairman of TauRx Therapeutics Ltd ...
So his product is Rember and not PBT2.